1-3 of 3
Chris Cubitt, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

a Combination of Ex Vivo and Computational Models Predicts Clinical Response in MM Treatment Combinations of Proteasome Inhibitors, Imids, Nuclear Export Inhibitors and Alkylating Agents

Ariosto Silva, PhD, Maria Silva, M.Sc, Timothy Jacobson, B.S., Mark B Meads, PhD, Allison Distler, B.S., Aunshka Collins, BS, Chris Cubitt, PhD, Lia E Perez, MD, Rachid Baz, MD, Dmitri Rebatchouk, PhD, Robert Gatenby, MD, PhD, Kenneth H. Shain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3291.
https://doi.org/10.1182/blood.V128.22.3291.3291
Published: 2016
Journal Articles

A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma

Kenneth H. Shain, MD PhD, Ariosto Silva, PhD, Mark B Meads, PhD, Allison Distler, B.S., Timothy Jacobson, B.S., Robert Gatenby, MD, PhD, Rachid Baz, Maria Silva, M.Sc, Dmitri Rebatchouk, PhD, Chris Cubitt, PhD
Journal: Blood
Blood (2015) 126 (23): 501.
https://doi.org/10.1182/blood.V126.23.501.501
Published: 2015
Journal Articles

Melphalan and XPO1 Inhibitor Combination Therapy for the Treatment of Multiple Myeloma

Joel G Turner, PhD, Jana L Dawson, BS, Steven Grant, MD, Kenneth H. Shain, MD PhD, Yun Dai, MD PhD, Chris Cubitt, PhD, Rachid Baz, MD, Taiga Nishihori, MD, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Daniel M Sullivan, MD
Journal: Blood
Blood (2014) 124 (21): 2084.
https://doi.org/10.1182/blood.V124.21.2084.2084
Published: 2014